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Abstract
Background:  Presenilin-dependent  γ-secretase cleavage of several transmembrane proteins,
including amyloid-β precursor protein and Notch, mediates the intramembrane proteolysis to
liberate their intracellular domains that are involved in cellular signaling. Considering γ-secretase
inhibitors as therapeutics for Alzheimer's disease, understanding the physiologically and biologically
important substrate for γ-secretase activity in brains is emerging issue. To elucidate the molecular
mechanism and physiological role of γ-secretase, we screened candidate molecules for γ-secretase
substrates.
Results: We show that ephrin-B1, that participates in cell-cell repulsive and attractive signaling
together with its Eph receptor, constitutively undergoes ectodomain shedding and that the residual
membrane-tethered fragment is sequentially cleaved by γ-secretase to release the intracellular
domain. Furthermore, overexpression of membrane-tethered ephrin-B1 caused protrusion of
numerous cellular processes consisted of F-actin, that required the preservation of the most C-
terminal region of ephrin-B1. In contrast, soluble intracellular domain translocated into the nucleus
and had no effect on cell morphology.
Conclusion: Our findings suggest that ephrin-B is a genuine substrate for γ-secretase and regulates
the cytoskeletal dynamics through intramembrane proteolysis.
Background
Alzheimer disease (AD) is a neurodegenerative disorder
characterized pathologically by neuronal loss in the cere-
bral cortex accompanied by the deposition of amyloid β
peptides (Aβ) as senile plaques. Aβ is produced by
sequential proteolytic cleavages of the amyloid-β precur-
sor protein (APP) by a set of membrane-bound proteases
termed β- and γ-secretases. γ-Secretase is an unusual aspar-
tic protease that cleaves APP within the transmembrane
domain (TMD) [1]. Presenilins (PS) are highly conserved
polytopic transmembrane proteins that are mutated in a
majority of pedigrees of early-onset familial Alzheimer's
disease. PS represent the active site component of γ-secre-
tase, a multiprotein complex comprised of Nicastrin,
APH-1 and PEN-2 [2]. FAD-linked mutations in PS genes
cause an increase in the production of Aβ ending at posi-
tion 42, that most readily form amyloid deposits in AD
brains, implicating the seminal role of γ-secretase/PS com-
plex in the pathogenesis of AD.
It has been shown that a number of type I single-span
membrane proteins are cleaved by γ-secretase [3].
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Although γ-secretase is unable to cleave the full-length
(FL) form of these substrates, the membrane-tethered C-
terminal fragments (CTF) generated by ectodomain shed-
ding are processed by γ-secretase to liberate N-terminal
small fragments and C-terminal intracellular domains
(ICD) into luminal and cytoplasmic side, respectively.
The liberated ICD translocates into the nucleus and partic-
ipates in signal transduction (e.g., Notch [4]). Thus, the γ-
secretase-mediated intramembrane proteolysis is high-
lighted as a novel mode of proteolysis-dependent signal
transduction utilizing ICD [5]. Recently it was reported
that the administration of functional γ-secretase inhibi-
tors in rodents caused an alteration in lymphopoiesis and
intestinal cell differentiation through inhibition of Notch
signaling [1]. Thus, the understanding of the molecular
mechanism of the unusual mode of intramembrane pro-
teolysis is a critical problem for the development of APP-
specific γ-secretase inhibitors for the treatment of AD.
Although the cleavage sites of some substrates have been
identified, the amino acid sequences within the trans-
membrane domain that undergo γ-secretase cleavage
exhibit a loose homology. To elucidate the molecular
mechanism and physiological role of γ-secretase in brains,
we screened candidate molecules for γ-secretase substrates
using several criteria. Here we identified ephrin-B1 as a
novel substrate for γ-secretase-mediated intramembrane
proteolysis.
Results
Proteolytic processing of ephrin-B
Although several transmembrane proteins are reported as
a substrate for PS/γ-secretase-dependent intramembrane
cleavage, a low homology of the amino acid sequences of
transmembrane domain (TMD) has been found among
these substrates [5]. We searched the database for novel γ-
secretase substrates that suffice the characteristics of
known substrates using following criteria: i) type I trans-
membrane protein, ii) carrying a receptor/ligand struc-
ture, iii) engaged in cell-cell interaction, iv) undergoes
ectodomain shedding (or harboring a homologous
sequence to other proteins undergoing shedding at jux-
tamembrane region) v) an accumulation of endogenous
C-terminal fragment (CTF) in PS-depleted cells. We
selected some candidate molecules and analyzed the
membrane fractions from various cell lines including
MEFs from Psen1-/-/Psen2-/- (DKO) mice [6] by immunob-
lotting using commercially available antibodies against
the C-terminal region. We found that an antibody against
ephrin-B probed ~14–17 kDa bands corresponding to the
membrane-tethered CTF in various cell membranes, in
addition to ~40–50 kDa bands representing the endog-
enous full-length (FL) protein, and that these ~14–17 kDa
bands were accumulated in membranes from PS DKO
MEF (Fig. 1A). We also detected ~14–17 kDa bands that
reacted with an anti-ephrin-B antibody in membrane frac-
tions of adult mouse organs (Fig. 1B). Moreover, treat-
ment by a γ-secretase inhibitor, DAPT, caused a
concentration-dependent accumulation of endogenous
ephrin-B-CTF in COS cells (Fig. 1C). Finally, the accumu-
Immunoblot analysis of endogenous ephrin-B CTFs Figure 1
Immunoblot analysis of endogenous ephrin-B CTFs. 
Membrane fractions from cultured cells (A) and mouse 
organs (B) were subjected to immunoblot analyses using anti-
ephrin-B antibody. C) Immunoblot analysis of lysates from 
COS cells treated with a γ-secretase inhibitor DAPT. D) 
Immunoblot analysis of lysates from DKO cells expressing 
PS1.Molecular Neurodegeneration 2006, 1:2 http://www.molecularneurodegeneration.com/content/1/1/2
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lation of ephrin-B CTF was abolished by the overexpres-
sion of PS1 in DKO cells (Fig. 1D). Taken together, these
data raised the possibility that ephrin-B-CTF is processed
by PS-dependent γ-secretase under a physiological condi-
tion, in a similar manner to known substrates for γ-secre-
tase.
γ-Secretase cleaves membrane-tethered CTF within TMD
to liberate N-terminal soluble peptides and C-terminal
ICD after the processing by sheddase within the luminal
region [3]. Treatment by phorbol esters has been reported
to induce ectodomain shedding by activation of ADAMs
(a disintegrin and metalloprotease) (e.g., tumor necrosis
factor-α converting enzyme) or matrix metalloproteases
(MMPs) [7,8]. Importantly, GPI-anchored ephrin-A2 is
associated with TACE and cleaved upon binding with
EphA receptor [9]. Consistent with the prediction above,
overexpressed ephrin-B1 FL was cleaved to generate ~14–
17 kDa CTF, that was increased by treatment with phorbol
12-myristate 13-acetate (PMA) and further augmented by
preincubation with DAPT (Fig. 2A). Moreover, coincuba-
tion with GM6001, a specific MMP inhibitor, abolished
the accumulation of ephrin-B-CTF, suggesting that
ephrin-B FL is shed by matrix metalloprotease within the
luminal region. However, ephrin-B-ICD, the final product
of γ-cleavage, was hardly detected even in lysates of PMA-
treated ephrin-B-overexpressing cells. Several reports indi-
cated that γ-secretase-generated ICDs are hardly detected
in vivo because of their short half-lives due to proteasomal
degradation [3]. Consistent with this feature, treatment by
epoxomicin, a potent irreversible proteasome inhibitor,
caused an accumulation of ~10–12 kDa polypeptides (fig.
2B). These smaller bands disappeared upon treatment by
DAPT and/or GM6001, suggesting that the generation of
~10–12 kDa bands is mediated by MMP and γ-secretase
activity. Intriguingly, coincubation with DAPT and epox-
omicin caused a marked accumulation of ephrin-B-CTF,
which was abolished by GM6001, indicating that a frac-
tion of ephrin-B-CTF undergo proteasomal degradation.
Finally, incubation of membrane fractions from COS cells
at 37 degree caused de novo γ-secretase-dependent genera-
tion of ~10–12 kDa bands in a similar manner to that of
APP ICD (AICD) (Fig. 3A) [10,11]. These ~10–12 kDa
bands were never generated from membranes of mouse
embryonic fibroblasts (MEF) lacking Psen1/Psen2 (DKO)
(Fig. 3B). Taken together, these data suggest that endog-
enous ephrin-B FL (~40–50 kDa) is constitutively proc-
essed by MMP within luminal region to generate CTF
(~14–17 kDa), subsequently cleaved by γ-secretase and
liberates ICD (~10–12 kDa), the latter being rapidly
degraded by proteasome in cytoplasm.
PS-dependent γ-secretase cleavage of ephrin-B1
To further characterize the intramembrane proteolysis of
ephrin-B by γ-secretase, truncated forms of ephrin-B1
fused with myc/His tag at N and C terminus were ana-
lyzed (Fig. 4A). eB1∆E, that corresponds to CTF of ephrin-
B1 starting at Ser218 residue fused with a signal peptide,
was expressed as a 20 kDa protein, and its protein level
was increased by DAPT treatment, whereas no smaller
bands were detected (Fig. 5A). However, the accumula-
tion of a smaller ~17 kDa polypeptide was detected upon
epoxomicin treatment, which was abolished by coincuba-
tion with DAPT. Furthermore, de novo γ-secretase-depend-
ent generation of ICD-like smaller peptides was detected
in a cell-free γ-secretase assay using membranes of cells
transfected with eB1∆E (Fig. 5B). Next we constructed a
cDNA encoding eB1ICD, that corresponds to a predicted
γ-secretase product, starting at intramembranous Val260
residue, the latter being closest to the analogous cleavage
site of the previously reported ICDs (e.g., Notch [12]), and
C-terminally fused to a myc/His tag (Fig. 4A). eB1ICD was
detected only after epoxomicin treatment, but not affected
by DAPT (Fig. 5C). Thus, it seems reasonable to speculate
that ICD of ephrin-B is constitutively and directly gener-
ated from truncated eB1∆E by γ-secretase-mediated cleav-
Analysis of proteolytic processing of ephrin-B1 Figure 2
Analysis of proteolytic processing of ephrin-B1. A) 
Immunoblot analysis of COS cells overexpressing ephrin-B1 
(arrows). ephrin-B1-CTF (arrowheads) was increased by 
DAPT and PMA treatment, whereas GM6001 completely 
diminished the ephrin-B1-CTF. B) Effect of protease inhibi-
tors on endogenous ephrin-B CTF. Note that proteasome 
inhibition by epoxomicin caused an accumulation of CTF 
(arrowhead) and ICD (asterisk), that was abolished by 
GM6001 treatment.Molecular Neurodegeneration 2006, 1:2 http://www.molecularneurodegeneration.com/content/1/1/2
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age, but is highly labile because of its liability to
proteasomal degradation.
Truncated ErbB-4 receptor tyrosine kinase is a direct sub-
strate for γ-secretase activity. PDZ domain binding motif
at C terminus of ErbB-4 is suggested to be required for the
intramembrane proteolysis [13]. Ephrin-B1 also harbors a
PDZ domain binding motif consisting of Tyr-Lys-Val resi-
dues, that is thought to be crucial for the localization and
function of ephrin-B1 through protein-protein interaction
[14,15]. Furthermore, conserved tyrosines that are phos-
phorylated in response to stimulation by their ligands
(i.e., EphB receptors) play an important role(s) in reverse
signaling through phosphotyrosine-binding proteins [16-
19]. To examine the role of these functional motifs at C
terminus of ephrin-B1 in γ-secretase-mediated cleavage,
we generated a series of C-terminally truncated eB1∆E
cDNAs: eB1∆E∆tag that corresponds to ephrin-B-CTF
without C-terminal myc/His tag, eB1∆E∆tag∆YKV that
lacks the tag as well as the PDZ domain binding motif,
and eB1∆E∆34 that is deleted at the C-terminal 34 amino
acids including all conserved tyrosines and fused with a C-
terminal tag (Fig. 4B). Cell free assay using membrane
fractions from transfected cells revealed that all the C-ter-
minally modified eB1∆E derivatives were cleaved by γ-
secretase to generate ICD-like peptides (Fig. 6). These data
suggest that these protein-protein interaction motifs at the
C terminus of ephrin-B1 are dispensable for the γ-secre-
tase-mediated proteolysis.
γ-Secretase cleavage generates ICDs that in turn translo-
cate into the nucleus mediated by the nuclear localization
signals (NLS) and/or binding proteins [12]. Several ICDs
are shown to form transcriptionally active complex to
facilitate the transcription of downstream genes (e.g.,
AICD, NICD, CD44ICD) [3,5]. While there is no apparent
canonical NLS in the cytoplasmic domain of ephrin-B, a
basic amino acid cluster is located adjacent to the
cytosolic face. As the basic amino acid cluster is known to
function as NLS, we examined the fractionation analysis
of cell lysates transfected with eB1ICD or eB1ICD∆NLS
starting at Thr273 residue (Fig. 4A). eB1ICD polypeptides
accumulated in the Triton X-100-insoluble fraction con-
taining lamin A/C, whereas eB1ICD∆NLS was detected
only in soluble fraction (Fig. 7A). Immunofluorescence
analysis revealed that eB1ICD was chiefly localized within
nucleus as well as in the cytoplasmic region, whereas the
immunoreactivity of eB1ICD∆NLS was limited to the
cytoplasm (Fig. 7C,D). In contrast, eB1∆E localized at cell
membranes including Golgi area (Fig. 7B). These data
suggest that ICD of ephrin-B enters the nucleus utilizing
the basic amino acid cluster at the juxtamembrane region
as NLS. Collectively, our findings suggest that ephrin-B1 is
a genuine γ-secretase substrate, similarly to other authen-
tic substrates like Notch.
Cell-free γ-secretase assay for ephrin-B1 cleavage Figure 3
Cell-free γ-secretase assay for ephrin-B1 cleavage. A) 
Cell-assay using membranes from mock- or ephrin-B1-trans-
fected COS cells. Samples incubated at 4 degree (4), 37 
degree (37) or 37 degree with DAPT (D) were analyzed by 
immunoblotting by anti-ephrin-B antibody (Upper panel). 
Same fractions without incubation were indicated as "C". 
ephrin-B1 FL, ephrin-B-CTF and de novo generated ICD were 
shown by black arrow, arrowhead and asterisk, respectively. 
Endogenous APP (Lower panel) C-terminal stubs (white arrow-
head) were cleaved by γ-secretase to generate AICD (double 
asterisks). B) Cell-free assay of membranes from wild-type 
MEF (MEFwt) and MEF lacking Psen1 and Psen2 (DKO). 
ephrin-B-CTF and de novo generated ICD were indicated by 
arrowhead and asterisk.Molecular Neurodegeneration 2006, 1:2 http://www.molecularneurodegeneration.com/content/1/1/2
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Membrane-attached truncated ephrin-B1 induced 
numerous cellular protrusions
Ephrin-B is involved in the cell-cell contact-mediated sig-
naling in collaboration with Eph receptors (e.g., cell
migration and repulsion, neuritogenesis, angiogenesis)
[14,15]. Recent data implicated ephrin-B in the morpho-
genesis of cells by regulation of actin dynamics through its
phosphorylation and binding of partner proteins in cyto-
plasmic region [16-20]. To characterize the functional
impact of γ-secretase-mediated cleavage in the ephrin-B1
signaling with reference to actin polymerization, we ana-
lyzed the morphology of COS cells transfected with
ephrin-B1 derivatives. Intriguingly, several filopodia-like
cellular processes that were highly enriched in actin fila-
ments protruded from cells transfected with eB1∆E (Fig.
8). The total length of cellular processes was increased by
DAPT treatment (1.4 fold, p < 0.05). In contrast, overex-
pression of eB1ICD did not elicit cellular protrusions (Fig.
7C). Importantly, eB1∆E∆34 also did not enhance the
generation of cellular protrusions, suggesting that the
most C-terminal region of ephrin-B that encompasses
conserved tyrosines is indispensable for the induction of
actin polymerization. These data suggest that eB1∆E regu-
lates the actin dynamics of subplasmalemmal domain,
that is negatively regulated by the γ-secretase activity-
mediated cleavage.
Discussion
Ephrin-B is a transmembrane protein that is implicated in
bidirectional intercellular signaling in cooperation with
its cognate receptor tyrosine kinase, Eph receptor [14,15].
Eph-ephrin binding induces the "forward signaling"
through activation of the tyrosine kinase domain of Eph
receptor. Moreover, ephrins also act as a receptor for Eph
and recruit signaling into the host cell, which is referred to
as the "reverse signaling". The cytoplasmic domain of
ephrin-B ligands, that contains conserved tyrosine resi-
dues, mediates the phosphorylation-dependent and -
independent reverse signaling, in cooperation with its
binding proteins in FL form. Here, we show that ephrin-B
is endoproteolyzed by metalloprotease (e.g., MMP) and
then by γ-secretase. We also found that N-terminally trun-
cated ephrin-B2 also is the substrate for γ-secretase (data
not shown), suggesting that this proteolytic process is a
common metabolic pathway for ephrin-B family proteins.
Finally, membrane-tethered cytoplasmic domain of
ephrin-B1 facilitated the formation of cellular protrusions
enriched in polymerized actin, that is negatively regulated
by γ-secretase activity. The liberated ICD translocated into
the nucleus. Our findings suggest that ephrin-B-mediated
Proteolytic processing of overexpressed ephrin-B1 deriva- tives Figure 5
Proteolytic processing of overexpressed ephrin-B1 
derivatives. A) Proteasome and γ-secretase inhibitor ("epo" 
and "DAPT", respectively) treatments on cells expressing 
eB1∆E (black arrowhead). Proteolytically-generated ICD was 
shown by asterisk. DAPT inhibited the processing of eB1∆E 
as well as endogenous APP (accumulation of C-terminal stub, 
white arrowhead in lower panel). B) Cell-free assay using COS 
membrane expressing eB1∆E. de novo generated ICDs from 
eB1∆E (black arrowhead) and APP C-terminal stub (white 
arrowhead) were indicated by asterisk and double asterisks, 
respectively. C) Inhibitor treatments (same as A) on cells 
expressing eB1ICD (asterisk). Accumulation of C-terminal 
stub (white arrowhead) by DAPT was shown at lower panel.
Schematic depiction of ephrin-B1 derivatives used in this  study Figure 4
Schematic depiction of ephrin-B1 derivatives used in 
this study. A) N-terminally truncated ephrin-B1 derivatives. 
B) C-terminally truncated eB1∆E derivatives. Putative amino 
acid sequence recognized by sheddase is underlined. Trans-
membrane domain is shown in bold. PDZ domain binding 
region (YKV) and Myc/His tag are indicated by shaded box 
and oval, respectively. Numbers indicate the residues in 
ephrin-B1 FL protein.Molecular Neurodegeneration 2006, 1:2 http://www.molecularneurodegeneration.com/content/1/1/2
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proteolysis-dependent signaling is regulated by the γ-
secretase activity.
Several transmembrane proteins including kinase-type
receptors are now known to undergo γ-secretase cleavage
after ectodomain shedding [3,5]. We screened novel sub-
strates of γ-secretase using several criteria that are com-
mon to known substrates. Although the proteolytic
processing of ephrin-B has not been reported, ephrin-A2,
GPI-anchored type ephrin ligand, is cleaved by ADAM10/
Kuzbanian upon activation by its cognate receptor, and
this process is implicated in Eph-ephrin-A mediated
axonal repulsion [9]. Our finding that ephrin-B is shed by
metalloprotease suggest that Eph-ephrin-B interaction-
mediated repulsion might also be regulated by proteoly-
sis, in a similar manner to Notch [3]. However, recent
reports showed that ephrin-B-mediated repulsion is regu-
lated by trans-endocytosis after engagement with EphB
receptor [19,20]. Furthermore, we observed that treat-
ment of ephrin-B expressing cells with clustered EphB2
fusion protein had no effect on shedding as well as γ-
secretase-mediated cleavage of ephrin-B (data not
shown). We also found that ephrin-B stub undergoes γ-
secretase-dependent intramembrane cleavage independ-
ently of its cytoplasmic C terminus, that contains a PDZ
domain binding motif and conserved tyrosines. These
findings suggest that γ-secretase cleavage of ephrin-B is
not regulated by a protein-protein interaction within its
C-terminal region. These data also indicate that the prote-
olytic processing of ephrin-B represents a constitutive sig-
naling or metabolic pathway, that may be independent of
the interaction with EphB2 receptor in COS cells. How-
ever, it has been shown that ephrin-B can interact with
other EphB receptors including EphA4. Further character-
ization using a complete set of Eph receptors and/or cell
lines is needed for the elucidation of the precise role of
proteolytic processing of ephrin-B in its signaling.
To date, functions of γ-secretase-generated ICD as tran-
scriptional activator (i.e., Notch, APP, CD44) or repressor
(i.e., Jagged, N-cadherin) within nucleus have been
reported [3]. We found that proteolytically generated
eB1ICD, that is highly labile, localizes to the nucleus.
Moreover, deletion of the acidic amino acid stretch
located at the cytosolic face diminished the nuclear local-
ization of this intracellular fragment, inferring its role as a
nuclear transcriptional regulator. Although eB1ICD lacks
known transactivation domain, intracellular domains of a
subset of γ-secretase substrates interact with co-transcrip-
tional activators after cleavage to facilitate nuclear translo-
cation and/or transcriptional regulation (i.e, RBPJk for
Notch [21], Fe65 for APP [22], YAP for ErbB-4 [23]). Fur-
ther proteomic and genetic approach will be needed to
clarify if eB1ICD regulates gene transcription.
Membrane-tethered eB1∆E induced protrusion of a
numerous actin-rich cellular processes. Most importantly,
DAPT treatment increased the total length of these protru-
sions induced by expression of eB1∆E. From these data, it
is reasonable to speculate that the ephrin-B1-stub after
ectodomain shedding may gain an activity to promote
actin polymerization, that is subsequently down-regu-
lated by γ-secretase-mediated cleavage. It is well known
that Eph-ephrin-B signaling controls cell motility and
eB1ICD translocated into the nucleus Figure 7
eB1ICD translocated into the nucleus. A) Immunoblot 
analysis of total (input), Triton-soluble (sup) or -insoluble 
(ppt) lysates from COS cells expressing eB1ICD (arrow) or 
eB1ICD∆NLS (arrowhead) using anti-myc (upper panel) or 
anti-lamin A/C (lower panel). B), C) and D) were the repre-
sentative results of immunocytochemical analysis of COS 
cells expressing eB1∆E, eB1ICD and eB1ICD∆NLS, respec-
tively, using anti-myc antibody. Nucleus and golgi area were 
indicated by arrows and arrowhead, respectively.
Proteolytic processing of overexpressed eB1∆E derivatives Figure 6
Proteolytic processing of overexpressed eB1∆E 
derivatives. Cell-free assay using COS membranes express-
ing eB1∆E∆tag (left), eB1∆E∆tag∆YKV (middle) and 
eB1∆E∆34 (right). Antibodies used were indicated below the 
panels. All derivatives (arrowheads) were cleaved to generate 
ICD-like peptides (asterisks) by γ-secretase activity.Molecular Neurodegeneration 2006, 1:2 http://www.molecularneurodegeneration.com/content/1/1/2
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adhesion through actin polymerization/depolymeriza-
tion [14,15]. Furthermore, Eph-ephrin-B interaction
mediates trans-endocytosis/retraction locally at contact
sites between receptor cells and ligand cells, in a manner
dependent on actin polymerization by Rac-signaling in
receptor cells [16-20]. Several actin binding/regulating
proteins (e.g., Grb4) were implicated in the regulation of
actin dynamics through association with phospho-tyro-
sines in ephrin-B ICD [16,17,24-26]. Consistent with this,
eB1∆E∆34, that lacks the Grb4-binding region, failed to
promote protrusion of processes, and DAPT treatment
without overexpression of eB1∆E had no effect on cellular
morphology. Intriguingly, genetic analysis revealed that
several mutations in human ephrin-B1 gene are linked to
familial and sporadic forms of craniofrontonasal syn-
drome (CFNS) [27,28]. As ephrin-B1 knockout mice
showed similar defects in skeletal patterning [29,30],
these CFNS-linked mutations are most likely leads to a
loss-of-function of ephrin-B1. Of note, some CFNS-linked
mutations cause a frameshift at the C terminus resulting
in a loss of Grb4 binding site of ephrin-B1 [31]. Thus, the
most C-terminal region of ephrin-B1 is indispensable for
ephrin-B signaling, to which γ-secretase activity might act
as a negative regulator. This negative regulation of ephrin-
B signaling mediated by γ-secretase activity is very similar
to what has been recently reported for deleted in colorec-
tal cancer (DCC) in synaptic function [32].
While several transmembrane proteins are reported as
substrate for γ-secretase [5], little information is available
for the physiological significance in vivo of the intramem-
brane cleavage of these substrates other than Notch [4].
However, considering the fact that Eph-ephrin-B signaling
shows functional synergy with Notch-Delta/Jagged signal-
ing in somitegenesis [33,34] and vasoculogenesis [35], γ-
secretase might be an important signaling component in
these bi-directional signaling at multiple points. Our find-
ings on the proteolytic processing of ephrin-B provide
information about adverse side effects of γ-secretase
inhibitors for the treatment of Alzheimer disease, as well
as a novel direction for understanding the molecular
mechanism of Eph-ephrin-B signaling.
Materials and methods
Construction of expression plasmid
A full-length cDNA encoding human ephrin-B1 was sub-
cloned into a pcDNA3.1/Hyg vector (Invitrogen) from
I.M.A.G.E clone (clone ID 3867060) (Invitrogen). cDNAs
encoding eB1∆E, eB1∆E∆tag, eB1∆E∆YKV, eB1∆E∆34,
eB1ICD and eB1ICD∆NLS were amplified by PCR using
following primer pairs: 5'-AGCTTGAGTGGCCCAGGT-
GCA-3' as a sense primer and 5'-GAATCCGAGACCTTG-
TAGTAGAT-3' as an antisense primer for eB1∆E, 5'-
TACTACAAGGTCTGATCGGATCCAAGCTTGTGTGGT-
GGAATTCTG-3' as a sense primer and 5'-
CAGAATTCCACCACACAAGCTTGGATCCGATCAGAC-
CTTGTAGTA-3' as an antisense primer for eB1∆E∆tag, 5'-
GCGAACATCTACTGATCGGATCCAAGCTTGTGTGGT-
GGAATTCTG-3' as a sense primer and 5'-
CAGAATTCCACCACACAAGCTTGGATCCGATCAGTA-
GATGTTCGC-3' as an antisense primer for eB1∆E∆YKV,
5'-CCCAAGCTTGAGTGGCCCAGGTGCA-3' as a sense
primer and 5'-GGGGGATCCGAGTTGTTCTCTGTAGT-3'
as an antisense primer for eB1∆E∆34, 5'-GGTACCACCAT-
GGTCCTACTACTG-3' as a sense primer and 5'-GGATC-
CGACCTTGTAGTAGAT-3' as an antisense primer for
eB1ICD, 5'-CCCGGTACCACCATGACACAGCAGCG-
GGCG-3' as a sense primer and 5'-GGGGGATCCGAC-
CTTGTAGTAGAT-3' as an antisense primer for
eB1ICD∆NLS.
Cell culture, transfection and retroviral infection
Cell lines including SV40-transformed mouse embryonic
fibroblasts (MEF) derived from wild-type (wt) or PSen1-/-
PSen2-/-  (DKO) littermates (provided by Dr. B. De
Strooper) were maintained as described [6]. Transient
transfections of cDNAs into cells were performed by
DEAE-dextran method (for COS cells), or using lipo-
fectAMINE (Invitrogen) according to manufacturer's
instructions [36]. Retroviral infection was performed as
previously described [37]. To analyze the effect of pro-
tease inhibitors (i.e., N-[N-(3,5-difluorophenacetyl)-L-
alanyl]-(S)-phenylglycine  t-butyl ester (DAPT) (kindly
provided by Drs. T. Kan and T. Fukuyama, The University
of Tokyo [38]), GM6001 (Chemicon) and epoxomicin
(SIGMA)) on the metabolism of ephrin-B and its deriva-
tives, COS cells were cultured in DMEM in the presence of
Immunocytochemical analysis of COS cells expressing eB1∆E  and eB1∆E∆34 Figure 8
Immunocytochemical analysis of COS cells express-
ing eB1∆E and eB1∆E∆34. COS cells were transfected 
with mock (A, E), eB1∆E (B, C, F, G) or eB1∆E∆34 (D, H) 
and treated with DMSO (A-D) or DAPT (E-H). Fixed cells 
were probed with anti-myc (Green) and Rhodamin-Phalloidin 
(Red) for eB1∆E and F-actin, respectively.Molecular Neurodegeneration 2006, 1:2 http://www.molecularneurodegeneration.com/content/1/1/2
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various concentrations of inhibitors for 24 hr and har-
vested.
Cell-free γ-secretase assay
Membrane pellets were prepared as previously described
and stored at -80 degree until use [39-42]. All procedures
were performed at 4 degree. Membrane pellets were resus-
pended in 1 × γ buffer (-C) (10 mM HEPES, pH7.4, 150
mM NaCl, 10% glycerol, 5 mM EDTA, 5 mM 1,10-phen-
anthroline, 10 µg/ml phosphoramidon, Complete pro-
tease inhibitor cocktail (Roche Biochemicals)) with or
without indicated inhibitors at 4 or 37 degree for 6–16
hrs. Control reactions were performed in the presence of
1% DMSO. The reaction was stopped by adding the sam-
ple buffer and boiling for 2 min. For the detection of de
novo generated products, samples were separated by SDS-
PAGE and analyzed by immunoblotting.
Reagents and immunochemical analyses
Antibodies and reagents were purchased from Cell Signal-
ing Technology (anti-myc 9B11), CHEMICON Interna-
tional (anti-lamin A/C), Molecular Probes (Alexa Fluor
488 anti-mouse IgG or Rhodamin-Phalloidin), Roche
applied sciences (anti-c-myc 9E10), Santa Cruz (anti-
ephrin-B1(C-18)) or SIGMA (anti-α-tubulin DM1A).
Anti-G1L3 against PS1 loop region was described previ-
ously [40]. Anti-APP antibody C4 is a gift from Dr. Y. Ihara
(The University of Tokyo). For preparation of Triton X-
100 soluble/insoluble fractions, cells were directly lysed
in HEPES buffer containing 1% Triton X-100 and centri-
fuged at 100,000 × g for 1 hr. Membrane preparation,
immunoblot or immunocytochemical analyses were per-
formed as previously described [36,37,39-42].
Cell morphology assay
Transfected COS cells were replated on poly-L-lysine
coated coverslips. After staining and mounting, images
were taken by CCD camera or FV300 Fluoview conforcal
microscopy (Olympus), and processed by Image J soft-
ware. We defined "cells extending protrusions" by the
number (>10) and the length (of the longest process that
is longer than 1/3 of the diameter of cell body) of proc-
esses.
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